窥得儿医药(QDEL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

QDEL 窥得儿医药

交易中 12-16 09:36:42 EST

28.99

-0.07

-0.24%

最高29.05	最低28.72	成交量1.42万
今开29.05	昨收29.06	日振幅1.14%
总市值19.69亿	流通市值18.16亿	总股本6,793万
成交额41.09万	换手率0.02%	流通股本6,265万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"QDEL","market":"US","secType":"STK","nameCN":"窥得儿医药","latestPrice":28.99,"timestamp":1765895772556,"preClose":29.06,"halted":0,"volume":14164,"delay":0,"floatShares":62648989,"shares":67931540,"eps":-17.444775,"marketStatus":"交易中","change":-0.07,"latestTime":"12-16 09:36:42 EST","open":29.05,"high":29.05,"low":28.72,"amount":410885.756404,"amplitude":0.011356,"askPrice":29.23,"askSize":10,"bidPrice":28.58,"bidSize":8,"shortable":3,"etf":0,"ttmEps":-17.444775,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":29.06,"preHourTrading":{"tag":"盘前","latestPrice":29.1,"preClose":29.06,"latestTime":"08:40 EST","volume":1313,"amount":38073.17917,"timestamp":1765892413661},"postHourTrading":{"tag":"盘后","latestPrice":29.06,"preClose":29.06,"latestTime":"19:34 EST","volume":45233,"amount":1314467.07,"timestamp":1765845241105},"volumeRatio":0.741324,"impliedVol":0.7214,"impliedVolPercentile":0.708},"requestUrl":"/m/hq/s/QDEL","defaultTab":"news","newsList":[{"id":"1127892146","title":"异动解读 | 窥得儿医药盘后大涨5.96%，Q3业绩超预期，成本节约显著","url":"https://stock-news.laohu8.com/highlight/detail?id=1127892146","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127892146?lang=zh_cn&edition=full","pubTime":"2025-11-06 07:09","pubTimestamp":1762384169,"startTime":"0","endTime":"0","summary":"周三盘后，窥得儿医药股价大涨5.96%，主要受益于公司发布的2025财年第三季度财报优于市场预期。更值得注意的是，调整后的EBITDA利润率达到25%，同比增加180个基点，这主要得益于超过4000万美元的成本节约措施。公司管理层对未来前景持乐观态度，将2025年全年收入指导范围缩小至26.8亿至27.4亿美元，调整后的EBITDA指导范围为5.85亿至6.05亿美元。投资者对公司的成本控制能力、国际市场拓展以及新产品开发进展表示认可，这些因素共同推动了股价的显著上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["QDEL"],"gpt_icon":0},{"id":"1134942288","title":"QuidelOrtho 2025财年Q3业绩会总结及问答精华：成本节约与国际市场推动增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1134942288","media":"业绩会速递","labels":["earningsCall"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1134942288?lang=zh_cn&edition=full","pubTime":"2025-11-06 07:06","pubTimestamp":1762384011,"startTime":"0","endTime":"0","summary":"调整后的EBITDA利润率达到25%，主要得益于超过4000万美元的成本节约措施。预计2025年全年COVID收入将保持在7000万至1亿美元之间。管理层预计2026年下半年或2027年初，随着美国捐赠者筛查收入的逐步减少，利润率将有所提升。QuidelOrtho在2025财年Q3实现了稳健的有机增长和显著的成本节约，尽管面临COVID和美国捐赠者筛查收入下降的挑战。公司通过国际市场的强劲表现和持续的成本节约措施，展现了其在全球诊断市场中的竞争力和增长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"earningsCall","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QDEL"],"gpt_icon":0},{"id":"1166305194","title":"窥得儿医药 - 美国实验室操作Vitros系统的商业推出将于今年晚些时候开始","url":"https://stock-news.laohu8.com/highlight/detail?id=1166305194","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166305194?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:04","pubTimestamp":1762171462,"startTime":"0","endTime":"0","summary":"窥得儿医药 - 美国实验室操作Vitros系统的商业推出将于今年晚些时候开始","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QDEL","BK4082","BK4198"],"gpt_icon":0},{"id":"1167381845","title":"窥得儿医药获得FDA 510(K)批准，推出Vitros™免疫诊断产品Hs肌钙蛋白I检测","url":"https://stock-news.laohu8.com/highlight/detail?id=1167381845","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167381845?lang=zh_cn&edition=full","pubTime":"2025-11-03 20:01","pubTimestamp":1762171274,"startTime":"0","endTime":"0","summary":"窥得儿医药获得FDA 510(K)批准，推出Vitros™免疫诊断产品Hs肌钙蛋白I检测","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QDEL","BK4082","BK4198"],"gpt_icon":0},{"id":"2573999779","title":"窥得儿医药盘中异动 早盘股价大跌5.04%报28.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573999779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573999779?lang=zh_cn&edition=full","pubTime":"2025-10-07 22:32","pubTimestamp":1759847540,"startTime":"0","endTime":"0","summary":"北京时间2025年10月07日22时32分，窥得儿医药股票出现波动，股价快速下挫5.04%。截至发稿，该股报28.11美元/股，成交量20.6202万股，换手率0.30%，振幅3.07%。窥得儿医药股票所在的医疗器械行业中，整体跌幅为0.24%。消息层面，截至22时32分，《花旗下调窥得儿医药至持有评级，下调目标价至33美元》资讯为影响窥得儿医药的重要信息。根据TipRanks数据显示，该分析师近一年总胜率为50.8%，总平均回报率为2.8%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100722322094be03e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025100722322094be03e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QDEL","BK4198","BK4082"],"gpt_icon":0},{"id":"2570686474","title":"窥得儿医药盘中异动 下午盘股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570686474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570686474?lang=zh_cn&edition=full","pubTime":"2025-09-27 01:23","pubTimestamp":1758907388,"startTime":"0","endTime":"0","summary":"北京时间2025年09月27日01时23分，窥得儿医药股票出现异动，股价快速拉升5.05%。截至发稿，该股报27.88美元/股，成交量73.7749万股，换手率1.09%，振幅3.88%。机构评级方面，在所有10家参与评级的机构中，60%的券商给予买入建议，30%的券商给予持有建议，10%的券商给予卖出建议。窥得儿医药股票所在的医疗器械行业中，整体涨幅为0.48%。窥得儿医药公司简介：快奥森多公司从事快速诊断检测解决方案的开发、制造和营销。如果其收入来自北美，则它产生大部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927012308a4467cf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927012308a4467cf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","QDEL","BK4082"],"gpt_icon":0},{"id":"2558661471","title":"窥得儿医药2025财年第二财季实现净利润-2.55亿美元，同比减少72.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661471","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558661471?lang=zh_cn&edition=full","pubTime":"2025-08-12 00:00","pubTimestamp":1754928032,"startTime":"0","endTime":"0","summary":"8月12日，窥得儿医药公布财报，公告显示公司2025财年第二财季净利润为-2.55亿美元，同比减少72.30%；其中营业收入为6.15亿美元，同比减少3.30%，每股基本收益为-3.77美元。从资产负债表来看，窥得儿医药总负债35.86亿美元，其中短期债务5.64亿美元，资产负债比为1.78，流动比率为1.13。机构评级：截至2025年8月12日，当前有8家机构对窥得儿医药目标价做出预测，其中目标均价为41.75美元，其中最低目标价为26.00美元，最高目标价为60.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000058a6dfeaa9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812000058a6dfeaa9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QDEL"],"gpt_icon":0},{"id":"1110170319","title":"异动解读 | 季度业绩超预期，窥得儿医药盘中大涨15.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1110170319","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110170319?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:44","pubTimestamp":1754487898,"startTime":"0","endTime":"0","summary":"医疗诊断公司窥得儿医药今日盘中大涨15.12%，引起市场广泛关注。这一显著涨幅主要受益于公司最新发布的季度财报业绩大幅超出市场预期。根据公司公布的财报显示，截至6月30日的季度中，窥得儿医药调整后每股收益达0.12美元，远超分析师平均预期的0.01美元。值得注意的是，窥得儿医药今年以来的股价表现并不理想，截至本季度末累计下跌45.9%。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["QDEL"],"gpt_icon":0},{"id":"2557837099","title":"窥得儿医药股价飙升12.90% 市值涨2.33亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557837099","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557837099?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:32","pubTimestamp":1754487168,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时32分，窥得儿医药股票出现异动，股价快速拉升12.90%。截至发稿，该股报26.74美元/股，成交量9.104万股，换手率0.13%，振幅4.27%。最近的财报数据显示，该股实现营业收入6.14亿美元，净利润-2.55亿美元，每股收益-3.77美元，毛利2.27亿美元，市盈率-3.91倍。窥得儿医药股票所在的医疗器械行业中，整体跌幅为0.05%。如果其收入来自北美，则它产生大部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213249a478d8a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213249a478d8a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QDEL","BK4082","BK4198"],"gpt_icon":0},{"id":"1197742386","title":"异动解读 | 季度业绩超预期，窥得儿医药盘前大涨10.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=1197742386","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197742386?lang=zh_cn&edition=full","pubTime":"2025-08-06 20:18","pubTimestamp":1754482730,"startTime":"0","endTime":"0","summary":"医疗诊断公司窥得儿医药今日盘前大涨10.90%，引起市场广泛关注。这一显著涨幅主要受益于公司最新发布的季度财报业绩大幅超出市场预期。根据公司公布的财报显示，截至6月30日的季度中，窥得儿医药调整后每股收益达0.12美元，远超分析师平均预期的0.01美元。值得注意的是，窥得儿医药今年以来的股价表现并不理想，截至本季度末累计下跌45.9%。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["QDEL"],"gpt_icon":0},{"id":"1168876873","title":"窥得儿医药二季度调整后每股收益0.12美元，大幅高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1168876873","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168876873?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:26","pubTimestamp":1754443607,"startTime":"0","endTime":"0","summary":"医疗诊断公司窥得儿医药在周二夜盘交易中股价大涨7.26%，主要受益于公司发布的季度业绩超出市场预期。根据公司公布的最新财报，窥得儿医药截至6月30日的季度调整后每股收益为0.12美元，大幅超过分析师平均预期的0.01美元。值得注意的是，窥得儿医药今年以来的股价表现并不理想，截至本季度末累计下跌45.9%。这次超预期的季度业绩可能成为公司股价反弹的催化剂，但投资者仍需密切关注公司未来的业务发展和市场表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QDEL"],"gpt_icon":0},{"id":"2557335994","title":"窥得儿医药盘中异动 下午盘股价大涨5.00%报23.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557335994","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557335994?lang=zh_cn&edition=full","pubTime":"2025-08-05 01:11","pubTimestamp":1754327498,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日01时11分，窥得儿医药股票出现异动，股价快速拉升5.00%。截至发稿，该股报23.95美元/股，成交量65.1108万股，换手率0.96%，振幅5.77%。机构评级方面，在所有10家参与评级的机构中，60%的券商给予买入建议，30%的券商给予持有建议，10%的券商给予卖出建议。窥得儿医药股票所在的医疗器械行业中，整体涨幅为0.62%。如果其收入来自北美，则它产生大部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080501113894cf4871&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080501113894cf4871&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QDEL","BK4082","BK4198"],"gpt_icon":0},{"id":"2556985382","title":"窥得儿医药盘中异动 快速跳水5.02%报23.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556985382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556985382?lang=zh_cn&edition=full","pubTime":"2025-08-01 03:40","pubTimestamp":1753990811,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日03时40分，窥得儿医药股票出现波动，股价快速下挫5.02%。截至发稿，该股报23.07美元/股，成交量104.763万股，换手率1.55%，振幅4.65%。机构评级方面，在所有10家参与评级的机构中，60%的券商给予买入建议，30%的券商给予持有建议，10%的券商给予卖出建议。窥得儿医药股票所在的医疗器械行业中，整体跌幅为1.57%。窥得儿医药公司简介：快奥森多公司从事快速诊断检测解决方案的开发、制造和营销。如果其收入来自北美，则它产生大部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801034011a46e1a71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801034011a46e1a71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QDEL","BK4198","BK4082"],"gpt_icon":0},{"id":"2551344182","title":"窥得儿医药盘中异动 股价大跌5.04%报28.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551344182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551344182?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:05","pubTimestamp":1752501927,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时05分，窥得儿医药股票出现波动，股价急速下挫5.04%。截至发稿，该股报28.81美元/股，成交量5.9917万股，换手率0.09%，振幅3.96%。机构评级方面，在所有10家参与评级的机构中，60%的券商给予买入建议，30%的券商给予持有建议，10%的券商给予卖出建议。窥得儿医药股票所在的医疗器械行业中，整体跌幅为0.14%。如果其收入来自北美，则它产生大部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220527a44a2d25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220527a44a2d25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QDEL","BK4082","BK4198"],"gpt_icon":0},{"id":"2549250275","title":"窥得儿医药盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549250275","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549250275?lang=zh_cn&edition=full","pubTime":"2025-07-08 22:33","pubTimestamp":1751985234,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日22时33分，窥得儿医药股票出现波动，股价急速拉升5.03%。截至发稿，该股报30.69美元/股，成交量13.9925万股，换手率0.21%，振幅4.45%。机构评级方面，在所有10家参与评级的机构中，70%的券商给予买入建议，20%的券商给予持有建议，10%的券商给予卖出建议。窥得儿医药股票所在的医疗器械行业中，整体涨幅为0.22%。窥得儿医药公司简介：快奥森多公司从事快速诊断检测解决方案的开发、制造和营销。如果其收入来自北美，则它产生大部分。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223354953af3f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708223354953af3f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","QDEL","BK4082"],"gpt_icon":0},{"id":"2518042442","title":"窥得儿医药盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518042442","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518042442?lang=zh_cn&edition=full","pubTime":"2025-03-11 03:05","pubTimestamp":1741633500,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日03时05分，窥得儿医药股票出现波动，股价急速下挫5.00%。截至发稿，该股报38.76美元/股，成交量38.7657万股，换手率0.57%，振幅6.41%。机构评级方面，在所有9家参与评级的机构中，56%的券商给予买入建议，33%的券商给予持有建议，11%的券商给予卖出建议。窥得儿医药股票所在的医疗器械行业中，整体跌幅为2.21%。公司的大部分收入来自北美。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030501a26aa14b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311030501a26aa14b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QDEL","BK4198","BK4082"],"gpt_icon":0},{"id":"2511753670","title":"窥得儿医药2024财年实现净利润-20.27亿美元，同比减少19969.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511753670","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511753670?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:01","pubTimestamp":1739635298,"startTime":"0","endTime":"0","summary":"2月16日，窥得儿医药公布财报，公告显示公司2024财年净利润为-20.27亿美元，同比减少19969.31%；其中营业收入为27.83亿美元，同比减少7.05%，每股基本收益为-30.16美元。从资产负债表来看，窥得儿医药总负债34.39亿美元，其中短期债务3.42亿美元，资产负债比为1.88，流动比率为1.23。机构评级：截至2025年2月16日，当前有8家机构对窥得儿医药目标价做出预测，其中目标均价为51.50美元，其中最低目标价为38.00美元，最高目标价为61.00美元。公司的大部分收入来自北美。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000205abd030f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000205abd030f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QDEL"],"gpt_icon":0},{"id":"2511694850","title":"窥得儿医药盘中异动 早盘大幅下挫5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511694850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511694850?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:16","pubTimestamp":1739546205,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时16分，窥得儿医药股票出现波动，股价快速跳水5.40%。截至发稿，该股报39.40美元/股，成交量22.5609万股，换手率0.34%，振幅6.82%。机构评级方面，在所有10家参与评级的机构中，60%的券商给予买入建议，30%的券商给予持有建议，10%的券商给予卖出建议。窥得儿医药股票所在的医疗器械行业中，整体涨幅为0.01%。公司的大部分收入来自北美。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231645962325e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214231645962325e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","BK4082","QDEL"],"gpt_icon":0},{"id":"2511652506","title":"窥得儿医药盘中异动 早盘股价大涨8.75%报43.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511652506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511652506?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457103,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，窥得儿医药股票出现异动，股价大幅上涨8.75%。截至发稿，该股报43.44美元/股，成交量7.0183万股，换手率0.10%，振幅2.15%。窥得儿医药股票所在的医疗器械行业中，整体涨幅为0.19%。其相关个股中，Tivic Health Systems, Inc.、窥得儿医药、Naya Biosciences, Inc.涨幅较大，Tivic Health Systems, Inc.、Reshape Lifesciences, Inc.、Intelligent Bio Solutions Inc.较为活跃，换手率分别为316.99%、2.08%、0.93%，振幅较大的相关个股有Tivic Health Systems, Inc.、Sight Sciences, Inc.、拜尔德医疗，振幅分别为12.34%、7.81%、6.26%。公司的大部分收入来自北美。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223144a244ab2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223144a244ab2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","BK4082","QDEL"],"gpt_icon":0},{"id":"1185447044","title":"QuidelOrtho 2024年第四季度调整后每股收益$0.63 超出预期$0.59，销售额$7.078亿 超出预期$6.9916亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1185447044","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185447044?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:17","pubTimestamp":1739395072,"startTime":"0","endTime":"0","summary":"QuidelOrtho报告其季度每股收益为0.63美元，超出分析师共识预期的0.59美元，超出幅度为6.78%。相比去年同期销售额7.426亿美元，同比减少4.69%。以上内容来自Benzinga Earnings专栏，原文如下：QuidelOrtho  reported quarterly earnings of $0.63 per share which beat the analyst consensus estimate of $0.59 by 6.78 percent. This is a 46.15 percent decrease over earnings of $1.17 per share from the same period last year.  The company reported quarterly sales of $707.80 million which beat the analyst consensus estimate of $699.16 million by 1.24 percent.  This is a 4.69 percent ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"QuidelOrtho 2024年第四季度调整后每股收益$0.63 超出预期$0.59，销售额$7.078亿 超出预期$6.9916亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QDEL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.quidel.com;www.orthoclinicaldiagnostics.com","stockEarnings":[{"period":"1week","weight":0.07},{"period":"1month","weight":0.3618},{"period":"3month","weight":-0.0159},{"period":"6month","weight":0.0258},{"period":"1year","weight":-0.2972},{"period":"ytd","weight":-0.3477}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"QuidelOrtho Corporation于2021年12月17日在特拉华州注册成立。公司在快速诊断检验解决办法的研发、生产喝水市场营销领域占据领导地位。这些诊断检验解决办法主要包括传染类疾病的应用、女性健康和胃肠道疾病。公司将其产品直接销售给终端客户以及经销商，无论售卖给谁，此产品都是用于专业使用，主要在医师办公室、医院、临床实验室、参考实验室、主要大学、零售诊所以及健康检验中心。公司通过全国和地区性的经销商以及直销网点将其产品在美国进行市场营销。在国际上，公司通过经销商的安排运作，主要在日本和欧洲出售其产品，并对其产品进行市场营销。","yearOnYearQuotes":[{"month":1,"riseRate":0.352941,"avgChangeRate":0.008449},{"month":2,"riseRate":0.382353,"avgChangeRate":-0.01851},{"month":3,"riseRate":0.542857,"avgChangeRate":-0.00509},{"month":4,"riseRate":0.485714,"avgChangeRate":0.000107},{"month":5,"riseRate":0.6,"avgChangeRate":0.02375},{"month":6,"riseRate":0.6,"avgChangeRate":0.030085},{"month":7,"riseRate":0.571429,"avgChangeRate":0.026716},{"month":8,"riseRate":0.514286,"avgChangeRate":0.022854},{"month":9,"riseRate":0.571429,"avgChangeRate":0.035968},{"month":10,"riseRate":0.428571,"avgChangeRate":0.020063},{"month":11,"riseRate":0.457143,"avgChangeRate":0.02035},{"month":12,"riseRate":0.571429,"avgChangeRate":0.021137}],"exchange":"NASDAQ","name":"窥得儿医药","nameEN":"Quidel"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"窥得儿医药(QDEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供窥得儿医药(QDEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"窥得儿医药,QDEL,窥得儿医药股票,窥得儿医药股票老虎,窥得儿医药股票老虎国际,窥得儿医药行情,窥得儿医药股票行情,窥得儿医药股价,窥得儿医药股市,窥得儿医药股票价格,窥得儿医药股票交易,窥得儿医药股票购买,窥得儿医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"窥得儿医药(QDEL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供窥得儿医药(QDEL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}